Drug Plan Design

artigo científico publicado em 1 de julho de 2014

mentions

First seen: há 4 mesesLast seen: há 12 dias

wikidata

Recent News5

benefitscanada.com·há 12 dias

Drug savings programs can alleviate cost pressures for private plans, impact plan design: expert

Savings programs for brand-name medications can alleviate some cost pressures for benefits plan sponsors and possibly impact plan design, says Jarred French, senior benefits consultant at BFL Canada.

benefitscanada.com·há 3 meses

Generic Ozempic could trim employer drug costs, but savings depend on plan design: expert

Health Canada has approved two generic versions of glucagon-like peptide-1 receptor agonist medication Ozempic, a move that could ease cost pressures for employer-sponsored benefits plans. The introdu

benefitscanada.com·há 4 meses

High-cost, weight management drugs reshaping Canada’s private drug plans: report

A new generation of ultra-high-cost therapies is reshaping benefits plan risk, while the arrival of generic glucagon-like peptide-1 receptor agonist medications is set to shift one of the largest drug

benefitscanada.com·há 4 meses

Weight management drugs, rare disease treatments expected to drive private drug plan costs in 2026: report

Weight management drugs and high-cost specialty treatments are expected to have the biggest impact on private drug plans this year, according to Telus Health’s annual drug pipeline report. It fo

benefitscanada.com·há 5 meses

2026 Chronic Disease at Work: Rising chronic disease rates among young people, women underscore need for inclusive programs

Rising rates of chronic illness among younger people and women are changing the picture of chronic disease in Canada, according to Sun Life data. Forty-five per cent of Canadians now live with a chron

Related Entities

1Health Benefits97×
2Benefits97×
3Drug Plans79×
4Benefits Canada News79×
5Health/Wellness78×
6Diabetes73×
7Biosimilars61×
8Chronic Disease60×
9Claims Data Analysis60×
10Glp-1 Drugs43×

Drug Plan Design — Entidade | Buobe